Stay updated with breaking news from Christopher Causey. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
True Wealth Design LLC grew its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 335,800.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 3,359 shares of the biotechnology company’s stock after purchasing an additional 3,358 shares during the quarter. True […]
True Wealth Design LLC grew its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 335,800.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 3,359 shares of the biotechnology company’s stock after purchasing an additional 3,358 shares during the quarter. True […]
Brandes Investment Partners LP increased its position in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 4.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,209 shares of the biotechnology company’s stock after buying an additional 689 shares during the quarter. Brandes […]
Brandes Investment Partners LP lifted its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 4.7% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 15,209 shares of the biotechnology company’s stock after buying an additional 689 shares […]
The Goldman Sachs Group upgraded shares of United Therapeutics (NASDAQ:UTHR – Free Report) from a sell rating to a neutral rating in a research report released on Monday, MarketBeat reports. The Goldman Sachs Group currently has $215.00 price target on the biotechnology company’s stock, up from their prior price target of $213.00. Other equities analysts […]